T. Rowe Price Associates’s Niagen Bioscience NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $789K | Buy |
|
|||||
|
2025
Q1 | $354K | Sell |
|
|||||
|
2024
Q4 | $304K | Buy |
|
|||||
|
2024
Q3 | $202K | Hold |
|
|||||
|
2024
Q2 | $151K | Buy |
|
|||||
|
2024
Q1 | $137K | Hold |
|
|||||
|
2023
Q4 | $57K | Hold |
|
|||||
|
2023
Q3 | $58K | Hold |
|
|||||
|
2023
Q2 | $62K | Hold |
|
|||||
|
2023
Q1 | $61K | Hold |
|
|||||
|
2022
Q4 | $66K | Buy |
|
|||||
|
2022
Q3 | $28K | Hold |
|
|||||
|
2022
Q2 | $38K | Sell |
|
|||||
|
2022
Q1 | $131K | Buy |
|
|||||
|
2021
Q4 | $133K | Sell |
|
|||||
|
2021
Q3 | $230K | Buy |
|
|||||
|
2021
Q2 | $250K | Buy |
|
|||||
|
2021
Q1 | $171K | Sell |
|
|||||
|
2020
Q4 | $135K | Buy |
|
|||||
|
2020
Q3 | $67K | Buy |
|